##plugins.themes.academic_pro.article.sidebar##

Submitted
Aug 1, 2022
Published
Oct 1, 2022
Download
PDF
Statistic
Read Counter : 224 Download : 287

Main Article Content

Abstract

COVID-19 is a disease caused by SARS-CoV-2. This disease quickly developed into a worldwide pandemic. In China, comorbidities are found in a quarter of COVID-19 patients. Cardiovascular comorbidity ranks third most compared to other comorbidities. However, in Indonesia there is no data related to the characteristics of COVID-19 patients with comorbidities and what types of cardiovascular disease are found.The design of this research is descriptive research with quantitative research methods.  This research data was obtained by total sampling technique from medical record data. This research was conducted at RSPAL dr.  Ramelan Surabaya in June – August 2021 because on that month, Indonesia experienced the highest spike in COVID-19 cases.


The results showed that COVID-19 patients with cardiovascular comorbidities disease have positive RT-PCR results and are dominated by leukocytosis, neutrophilia, lymphopenia, high level of D-dimer, and pneumonia bilateral. The cardiovascular disease that become the most common comorbidity is hypertension.

Article Details

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

References

1. World Health Organization (WHO). WHO Coronavirus Disease (COVID-19) Dashboard [Internet]. who.int. World Health Organization; 2020. p. 1. Available from: https://covid19.who.int/

2. Satuan Tugas Penanganan COVID-19. Peta Sebaran [Internet]. https://Covid19.go.id/Peta-Sebaran. 2020. p. 1. Available from: https://covid19.go.id/peta-sebaran

3. Kemenkes RI. Pedoman Pencegahan dan Pengendalian Coronavirus Disease (COVID-19). 4th ed. Aziza dr. L, Aqmarina A, Ihsan M, editors. Germas. Jakarta: Kementerian Kesehatan RI; 2020. 136 p.

4. Cozzi D, Albanesi M, Cavigli E, Moroni C, Bindi A, Luvarà S, et al. Chest X‑ray in new Coronavirus Disease 2019 (COVID‑19) infection: fndings and correlation with clinical outcome. Radiol Medica. 2020;125:730–7.

5. Kementerian Kesehatan Republik Indonesia. Pedoman Pencegahan dan Pengendalian Coronavirus Disease (COVID-19). 5th ed. Aziza L, Aqmarina A, Ihsan M, editors. Germas. Jakarta: Kementrian Kesehatan Republik Indonesia; 2020. 214 p.

6. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–13.

7. Guan W, Liang W, Zhao Y, Liang H, Chen Z, Li Y, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020;55:2000547.

8. Nishiga M, Wang DW, Han Y, Lewis DB, Wu JC. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol. 2020;17:543–58.

9. Vetrano DL, Tazzeo C, Palmieri L, Marengoni A, Zucchelli A, Lo Noce C, et al. Comorbidity status of deceased COVID-19 in-patients in Italy. Aging Clin Exp Res. 2021;33(8):2361–5.

10. European Society of cardiology. ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic. European Society of cardiology. 2020.

11. Petrilli CM, Jones SA, Yang J, Rajagopalan H, O’Donnell L, Chernyak Y, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: Prospective cohort study. BMJ. 2020;369.

12. Sanchis-Gomar F, Perez-Quilis C, Leischik R, Lucia A. Epidemiology of coronary heart disease and acute coronary syndrome. Ann Transl Med. 2016;4(13):256.

13. Hakim LN. Urgensi Revisi Undang-Undang tentang Kesejahteraan Lanjut Usia. Aspir J Masal Sos. 2020;11(1):43–55.

14. Australian Government Department of Health. Coronavirus (COVID-19) case numbers and statistics [Internet]. Australian Government Department of Health; 2022. p. 1. Available from: https://www.health.gov.au/health-alerts/covid-19/case-numbers-and-statistics

15. Jayusman I, Shavab OAK. Studi Deskriptif Kuantitatif Tentang Aktivitas Belajar Mahasiswa dengan Menggunakan Media Pembelajaran Edmodo dalam Pembeljaran Sejarah. J Artefak. 2020;7(1):13–20.

16. Rahman MA, Shanjana Y, Tushar MI, Mahmud T, Rahman GMS, Milan ZH, et al. Hematological abnormalities and comorbidities are associated with COVID-19 severity among hospitalized patients: Experience from Bangladesh. PLoS One. 2021;16(7):16.

17. Goudouris ES. Laboratory diagnosis of COVID-19. J Pediatr (Rio J). 2021;97:7–12.

18. Yan X, Li F, Wang X, Yan J, Zhu F, Tang S, et al. Neutrophil to lymphocyte ratio as prognostic and predictive factor in patients with coronavirus disease 2019: A retrospective cross-sectional study. J Med Virol. 2020;1–9.